{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-02",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "52652-8001",
      "generic_name": "ZONISAMIDE",
      "labeler_name": "Azurity Pharmaceuticals, Inc.",
      "brand_name": "ZONISADE",
      "active_ingredients": [
        {
          "name": "ZONISAMIDE",
          "strength": "100 mg/5mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "52652-8001-1",
          "description": "1 BOTTLE in 1 CARTON (52652-8001-1)  / 150 mL in 1 BOTTLE",
          "marketing_start_date": "20220715",
          "sample": false
        }
      ],
      "listing_expiration_date": "20261231",
      "openfda": {
        "manufacturer_name": [
          "Azurity Pharmaceuticals, Inc."
        ],
        "rxcui": [
          "2606782",
          "2606788"
        ],
        "spl_set_id": [
          "ac16fa15-32e9-4f92-8bc6-d8d41ae002c6"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0352652800119"
        ],
        "nui": [
          "N0000175753",
          "N0000008486",
          "M0020790",
          "N0000000235",
          "N0000185503"
        ],
        "pharm_class_epc": [
          "Anti-epileptic Agent [EPC]"
        ],
        "pharm_class_pe": [
          "Decreased Central Nervous System Disorganized Electrical Activity [PE]"
        ],
        "pharm_class_cs": [
          "Sulfonamides [CS]"
        ],
        "pharm_class_moa": [
          "Carbonic Anhydrase Inhibitors [MoA]",
          "P-Glycoprotein Inhibitors [MoA]"
        ],
        "unii": [
          "459384H98V"
        ]
      },
      "marketing_category": "NDA",
      "dosage_form": "SUSPENSION",
      "spl_id": "063fd04f-90bf-4b1f-99fe-4e2cdb5b1eea",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20220715",
      "product_id": "52652-8001_063fd04f-90bf-4b1f-99fe-4e2cdb5b1eea",
      "application_number": "NDA214273",
      "brand_name_base": "ZONISADE",
      "pharm_class": [
        "Anti-epileptic Agent [EPC]",
        "Carbonic Anhydrase Inhibitors [MoA]",
        "Decreased Central Nervous System Disorganized Electrical Activity [PE]",
        "P-Glycoprotein Inhibitors [MoA]",
        "Sulfonamides [CS]"
      ]
    }
  ]
}